Javelin Pharmaceuticals Report issue

For profit Phase 1 Phase 3
Founded: Cambridge MA United States (1998)
Status: Acquired by Hospira (2010) → now Pfizer (2015)

Organization Overview

First Clinical Trial
2001
NCT00488787
First Marketed Drug
2014
diclofenac (voltaren)
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Javelin Pharmacueticals | JAVELIN PHARMS INC